Physician

Aasim Rehman, M.D.

According to 2025 Medicare claims, Aasim Rehman, M.D. (NPI: 1265634158) practices rheumatology, with the plurality of this provider's patient population coming from Muskingum, OH. This provider's primary affiliated billing organization is GENESIS MEDICAL GROUP LLC (NPI: 1063663433; TIN: 263428410) and primary practice location at 43701-1896. Rehman is affiliated with the ACO West Virginia (ACO ID: A3563) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Rehman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 450 traditional Medicare patients, billed 2,030 HCPCS/CPT codes, and received $89,146 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 3,919 prescription claims across 652 beneficiaries totaling $4,220,589 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 2 records totaling $31. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,593,915 and ending at $4,220,589. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	447	1,257	$68,943
2016	615	1,611	$70,803
2017	685	1,660	$85,036
2018	694	1,626	$79,120
2019	597	1,402	$67,967
2020	532	1,278	$66,425
2021	499	1,123	$73,015
2022	516	1,268	$75,601
2023	485	1,146	$72,861
2024	450	2,030	$89,146

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	419	2,523	$1,593,915
2016	582	4,335	$2,859,328
2017	630	4,653	$2,991,124
2018	685	4,532	$3,194,917
2019	630	3,408	$2,912,110
2020	535	2,804	$2,851,666
2021	495	2,256	$2,471,138
2022	568	2,943	$3,453,815
2023	531	2,534	$2,636,568
2024	652	3,919	$4,220,589

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	51	66	$99
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	109	109	$89
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	409	908	$66
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	27	29	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	376	868	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	101	2,828	$777,495
Humira(Cf) Pen	Adalimumab	82	2,394	$629,104
Humira Pen	Adalimumab	40	1,120	$322,395
Benlysta	Belimumab	69	1,934	$274,163
Rinvoq	Upadacitinib	41	1,230	$260,647

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$31	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aasim Rehman, M.D.?

Tedicare shows public-source Medicare data for Aasim Rehman, M.D. (NPI 1265634158), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aasim Rehman, M.D. have ACO affiliation data?

Aasim Rehman, M.D. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Aasim Rehman, M.D.?

Aasim Rehman, M.D. is linked to GENESIS MEDICAL GROUP LLC (billing NPI 1063663433) in the available physician profile data.

Does Aasim Rehman, M.D. have Open Payments data?

Aasim Rehman, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.